GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NewGenIvf Group Ltd (NAS:NIVF) » Definitions » Piotroski F-Score

NIVF (NewGenIvf Group) Piotroski F-Score : 5 (As of Oct. 31, 2024)


View and export this data going back to 2024. Start your Free Trial

What is NewGenIvf Group Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

NewGenIvf Group has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for NewGenIvf Group's Piotroski F-Score or its related term are showing as below:

NIVF' s Piotroski F-Score Range Over the Past 10 Years
Min: 5   Med: 5   Max: 5
Current: 5

During the past 3 years, the highest Piotroski F-Score of NewGenIvf Group was 5. The lowest was 5. And the median was 5.


NewGenIvf Group Piotroski F-Score Historical Data

The historical data trend for NewGenIvf Group's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewGenIvf Group Piotroski F-Score Chart

NewGenIvf Group Annual Data
Trend Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A 5.00

NewGenIvf Group Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score N/A - N/A - 5.00

Competitive Comparison of NewGenIvf Group's Piotroski F-Score

For the Medical Care Facilities subindustry, NewGenIvf Group's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NewGenIvf Group's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where NewGenIvf Group's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was $0.13 Mil.
Cash Flow from Operations was $-1.77 Mil.
Revenue was $5.14 Mil.
Gross Profit was $1.68 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (2.905 + 1.647) / 2 = $2.276 Mil.
Total Assets at the begining of this year (Dec22) was $2.91 Mil.
Long-Term Debt & Capital Lease Obligation was $0.12 Mil.
Total Current Assets was $1.20 Mil.
Total Current Liabilities was $1.12 Mil.
Net Income was $0.46 Mil.

Revenue was $5.94 Mil.
Gross Profit was $1.54 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (1.413 + 2.905) / 2 = $2.159 Mil.
Total Assets at the begining of last year (Dec21) was $1.41 Mil.
Long-Term Debt & Capital Lease Obligation was $0.25 Mil.
Total Current Assets was $2.40 Mil.
Total Current Liabilities was $2.56 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

NewGenIvf Group's current Net Income (TTM) was 0.13. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

NewGenIvf Group's current Cash Flow from Operations (TTM) was -1.77. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=0.13/2.905
=0.04475043

ROA (Last Year)=Net Income/Total Assets (Dec21)
=0.459/1.413
=0.32484076

NewGenIvf Group's return on assets of this year was 0.04475043. NewGenIvf Group's return on assets of last year was 0.32484076. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

NewGenIvf Group's current Net Income (TTM) was 0.13. NewGenIvf Group's current Cash Flow from Operations (TTM) was -1.77. ==> -1.77 <= 0.13 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=0.119/2.276
=0.05228471

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=0.249/2.159
=0.11533117

NewGenIvf Group's gearing of this year was 0.05228471. NewGenIvf Group's gearing of last year was 0.11533117. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=1.201/1.122
=1.07040998

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=2.399/2.556
=0.9385759

NewGenIvf Group's current ratio of this year was 1.07040998. NewGenIvf Group's current ratio of last year was 0.9385759. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

NewGenIvf Group's number of shares in issue this year was 10.149. NewGenIvf Group's number of shares in issue last year was 10.149. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1.682/5.136
=0.32749221

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1.538/5.944
=0.25874832

NewGenIvf Group's gross margin of this year was 0.32749221. NewGenIvf Group's gross margin of last year was 0.25874832. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=5.136/2.905
=1.76798623

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=5.944/1.413
=4.20665251

NewGenIvf Group's asset turnover of this year was 1.76798623. NewGenIvf Group's asset turnover of last year was 4.20665251. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+0+0+1+1+1+1+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

NewGenIvf Group has an F-score of 5 indicating the company's financial situation is typical for a stable company.

NewGenIvf Group  (NAS:NIVF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


NewGenIvf Group Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of NewGenIvf Group's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


NewGenIvf Group Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Sukhumvit 21 Road, Asoke, 36/39-36/40, 13th Floor, PS Tower, Khlong Toei Nuea Sub-district, Watthana District, Bangkok, THA, 10110
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.